DEB-TACE Combined With Apatinib and PD-1 for the Treatment of Intrahepatic Cholangiocarcinoma

Clinical trial NCT04834674 · COMPLETED

Trial details

NCT number: NCT04834674
Sponsor: Sichuan Cancer Hospital and Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Intrahepatic Cholangiocarcinoma Transarterial Chemoembolization Apatinib PD-1 Antibody

Start date: 2024-07-01
Primary completion: 2026-04-05
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.